Developer docs
API playgroundTry for free, no card

Search company profiles

INOVAIT

Full company profile

uuid002fvlz

Namestring
INOVAIT
Legal namestring
INOVAIT
Websiteurl
inovait.ca
Company typeenum
Private
Founded yearint
2020
Descriptiontext

INOVAIT is a non-profit, membership-based national network founded in 2020 and hosted at the Sunnybrook Research Institute in Toronto, dedicated to advancing image-guided therapy (IGT) integrated with artificial intelligence across Canada. The organization is funded by the Government of Canada's Strategic Response Fund (part of the Strategic Innovation Fund) and is not incorporated as a separate commercial entity, operating instead as a program under SRI's governance. Its core offering is a platform of interconnected programs: non-dilutive funding vehicles (Pilot Fund up to $150K CAD per 9-12 month project; Focus Fund up to $2M CAD per 2-3 year project), experiential training (the Medventions fellowship and lecture series), networking events (annual Discovery Forum and IGT Symposium), and a health data licensing toolkit and governance framework designed to help Canadian healthcare institutions safely share data for AI commercialization.

INOVAIT does not generate commercial revenue or sell products; its operating model is that of a government-funded intermediary that channels capital, training, and ecosystem connectivity to Canadian medtech SMEs, academic institutions, hospital research centres, and not-for-profit organizations working on AI-enabled medical imaging, diagnostics, and precision treatments. As of mid-2026, the network had funded more than 100 collaborative R&D projects with cumulative sector infusion exceeding $128M, supporting named companies such as Perimeter Medical Imaging AI, KA Imaging, Hyivy Health, Vope Medical, Daxsonics, Synaptive Medical, Sonic Incytes, 16 Bit, Altis Labs, and Dova Health.

The organization maintains a small staff of approximately 10-12 members led by Co-Executive Directors Kullervo Hynynen (VP Research and Innovation at SRI) and Raphael Ronen (Director, Commercialization and Administration), supported by a board that includes executives from Fusion Pharmaceuticals, McKinsey, and Augmentr Inc. Distribution is primarily through membership enrollment, open funding calls, and in-person events, with strategic partnerships formalized in 2026 with DIGITAL (Canada's Global Innovation Cluster) and Mitacs (fellowship umbrella). The 2026 launch of the 'Navigating the Canadian Image-guided Therapy Sector' market research series extends INOVAIT's role from funder into sector intelligence provider.

Short descriptiontext

INOVAIT is a federally funded Canadian network that provides non-dilutive grants, training, and ecosystem connectivity to medtech SMEs, academic institutions, and hospitals working on AI-integrated image-guided therapy, operated from Sunnybrook Research Institute in Toronto.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
image-guided therapy network, medtech commercialization funding, AI medical imaging programs, health data licensing tools, medtech entrepreneur training
Industry3 codes
PRIMARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Commercial Physical & Biological Research8731
Product category
Medtech Innovation Network
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Government Funding (Strategic Response Fund)
TypeManaged Services
Description

INOVAIT receives funding from the Government of Canada's Strategic Response Fund (part of the Strategic Innovation Fund) to support the Canadian IGT sector, fuel better patient care, and develop image-guided therapy technologies. This non-dilutive funding is used to provide grants to member companies and institutions.

inovait.ca
2Membership Fees
TypeSubscription Recurring
Description

INOVAIT operates as a membership-based national network. Members receive exclusive access to events, funding opportunities, training programs, and networking with industry leaders in the IGT-AI sector.

inovait.ca
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details2 tiers
1Pilot Fund - Up to $150,000 for 9-12 month projects
ModelOtherBilling cadenceMulti-year contract
Notes

Non-dilutive, reimbursement-based funding for collaborative R&D projects integrating AI into IGT technologies. INOVAIT contributes up to one-third of eligible supported costs.

inovait.ca
2Focus Fund - Up to $2 million for 2-3 year projects
ModelOtherBilling cadenceMulti-year contract
Notes

Non-dilutive contributions for projects with excellent technical and clinical merit and highest probability of commercialization success.

inovait.ca
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Medventions
Description

A medtech innovation fellowship program that targets clinical needs and nurtures Canada's rising medtech talent base. Founded at Sunnybrook Research Institute, it immerses fellows in real clinical settings to identify unmet clinical needs and develop innovations in healthcare.

inovait.ca
+3 more records
Core offering1 text field

INOVAIT operates as Canada's national image-guided therapy (IGT) and artificial intelligence (AI) network, delivering a connected platform of programs that fund, train, and connect Canadian medtech ventures. Its core services include non-dilutive funding through the Pilot Fund (up to $150,000 CAD) and Focus Fund (up to $2 million CAD), experiential training through the Medventions fellowship program and lecture series, networking through the Discovery Forum and IGT Symposium, and health data licensing frameworks and toolkits. Members include Canadian SMEs, academic institutions, hospital research centres, and not-for-profit organizations working on AI integration in medical imaging, diagnostics, and image-guided therapeutics.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

INOVAIT is Canada's national image-guided therapy (IGT) and AI network that operates as a platform of interconnected programs rather than a single product. The core offerings include two non-dilutive funding vehicles—the Pilot Fund (up to $150K for 9-12 month projects) and Focus Fund (up to $2M for multi-year projects)—that support collaborative R&D integrating AI into medical imaging technologies. Complementing funding are the Medventions training programs (fellowship and lecture series) that develop medtech talent, networking events (Discovery Forum and IGT Symposium) that connect the ecosystem, and data licensing tools that enable responsible health data sharing for innovation. Together, these programs form a comprehensive commercialization support ecosystem for Canadian medtech companies.

Product and service9 records
1Pilot Fund
CategoryFunding Program
Description

Non-dilutive funding program providing up to $150,000 CAD per 9–12 month project, reimbursing up to one-third of eligible costs for collaborative R&D projects integrating AI with image-guided therapy technologies. Targets Canadian corporations, academic institutions, hospitals, and not-for-profit organizations.

2Focus Fund
CategoryFunding Program
Description

Non-dilutive funding program providing up to $2 million CAD per 2–3 year project for high technical and clinical merit projects with highest commercialization potential, supporting larger-scale IGT-AI development initiatives.

3Medventions Fellowship Program
CategoryTraining Program
Description

Elite medtech entrepreneur training program providing clinical immersion, mentorship, and prototyping funding to aspiring healthcare innovators. Operating in Ontario, Nova Scotia, and Newfoundland and Labrador through a formal partnership with Mitacs.

4Medventions Lecture Series
CategoryTraining Program
Description

Educational lecture series addressing the role of big data in image-guided therapy and the integration of AI data handling into IGT technologies, designed for students, entrepreneurs, and scientists seeking introductory knowledge of the field.

5Discovery Forum
CategoryNetworking Event
Description

Annual members-only flagship event featuring cutting-edge image-guided therapy technology showcases, panel discussions, and project progress presentations for academic-industry networking.

6IGT Symposium
CategoryNetworking Event
Description

Annual two-day scientific conference bringing together clinical and research communities for emerging diagnostic and therapeutic health technologies, including biomedical imaging, AI, machine learning, and image-guided therapeutics.

7Health Data Licensing Toolkit
CategoryResource / Tool
Description

Free toolkit for Canadian healthcare institutions to safely and responsibly share data for commercial development of AI technologies, including data licensing frameworks and governance guidelines.

8Principles for Safe, Ethical, and Trustworthy Canadian Health Data Licensing
CategoryFramework / Resource
Description

Framework document for healthcare institutions to confidently engage in health data licensing, grounded in transparency, ethical practices, patient representation, governance, and Indigenous data sovereignty.

9Navigating the Canadian Image-guided Therapy Sector Series
CategoryMarket Research
Description

Multi-installment market research initiative chronicling experiences of 30 Canadian IGT companies, analyzing funding sources, ecosystem gaps, and recommendations for sector growth.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-09
Description

Medventions Mitacs Umbrella agreement supporting fellowship programs across Canada (Ontario, Nova Scotia, and Newfoundland and Labrador) over two years. The partnership will support 39 internships within the Medventions program, equipping medtech entrepreneurs with hands-on clinical experience. The partnership formalizes a relationship that began in 2021.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-31
Description

MOU signed to formalize collaboration expanding opportunities for IGT founders and accelerating commercialization. Framework includes bi-directional referrals, cross-promotion of programming, exploration of joint co-innovation calls, and expanded participation in ecosystem-building activities. Builds on previous co-investments in Dova Health, 16 Bit, and Altis Labs.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

INOVAIT was established in 2020 at Sunnybrook Research Institute, which serves as the host organization. SRI is the research arm of Sunnybrook Health Sciences Centre, one of Canada's premier academic health sciences centres fully affiliated with the University of Toronto. SRI is home to the Centre for Research in Image-Guided Therapeutics.

4Dova Health
Strategic tierMinorTypeStrategic or Co-development Partner
Description

High-impact Canadian IGT company that has received co-investment support from both INOVAIT and DIGITAL at different stages of their journey.

financialpost.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

High-impact Canadian IGT company that has received co-investment support from both INOVAIT and DIGITAL at different stages of their journey.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

High-impact Canadian IGT company that has received co-investment support from both INOVAIT and DIGITAL at different stages of their journey.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major academic partner through Sunnybrook Research Institute affiliation. INOVAIT works with various university departments including Department of Medical Biophysics, Department of Biophysics, and Department of Chemistry for IGT research and commercialization.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner collaborating on multiple funded projects including KA Imaging's AI-based triage tool and Hyivy Health's AI-enabled therapy system.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major hospital research centre partner collaborating on projects including Vope Medical's CLARIS platform and Altis Labs' deep learning system for lung cancer treatment decisions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major Atlantic Canada health authority partner, recipient of INOVAIT Aurora Borealis Award, and partner in Medventions Atlantic program and various IGT research projects.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1BioEnterprise (Cleveland)
TypeEmerging player
Description

US medtech/healthtech commercialization hub providing advisory, capital, and program services to medical device start-ups. Operates a similar model of cohort-based commercialization support but is regional to Northeast Ohio rather than national.

TypeDirect peer
Description

Canadian national research network that funds internships and R&D collaborations between academia and industry. INOVAIT's Medventions Mitacs Umbrella Agreement partner; both operate as federal-network intermediaries funding applied research and talent development.

TypeBroad incumbent
Description

Seed-stage accelerator affiliated with the University of Toronto, hosting health-focused streams (CDL-Healthech). Similar Canadian innovation-ecosystem pedigree, but operating via equity-mentorship cohorts rather than non-dilutive grants.

TypeBroad incumbent
Description

Canada's largest urban innovation hub hosting healthtech ventures, programming, and capital connections. Operates a similar network-and-ecosystem model in Toronto, but with a much broader sector mandate than INOVAIT's IGT-specific focus.

TypeOthers
Description

Venture firm and accelerator network with health/biotech programs running cohort-based commercialization support. Comparable in building founder/venture ecosystems in healthtech, though capital-based (equity) rather than grant-based like INOVAIT.

TypeDirect peer
Description

Canadian medtech industry consortium funding collaborative R&D projects between SMEs, hospitals, and academia. Closely overlaps INOVAIT's mission of accelerating medtech commercialization via co-investment, training, and networking, with a similar funding-network business model.

TypeDirect peer
Description

Canada's Global Innovation Cluster for digital technologies, INOVAIT's newest MOU partner covering bi-directional referrals and co-investments. Operates the same non-dilutive matching-co-investment model on a larger stage across digital tech, making it the most direct analog to INOVAIT's IGT-AI mandate.

TypeDirect peer
Description

Ontario health-bioscience cluster that invests in and supports early-stage life sciences and healthtech companies, with programs for talent, capital, and commercialization. Comparable mission and instrument set to INOVAIT, though broader in therapeutic scope.

TypeBroad incumbent
Description

UK government-backed innovation agency funding late-stage R&D and commercialization in priority sectors including health and life sciences. Analogous in role as a national-level public innovation funder targeting medtech/healthcare innovation.

TypeRegional player
Description

Healthtech-focused accelerator and network focused on commercialization support in adjacent medtech and digital health. Comparable funding-and-network operating model but with different therapeutic emphasis and non-Canadian footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

INOVAIT

Medtech Innovation Networkinovait.ca

INOVAIT is a federally funded Canadian network that provides non-dilutive grants, training, and ecosystem connectivity to medtech SMEs, academic institutions, and hospitals working on AI-integrated image-guided therapy, operated from Sunnybrook Research Institute in Toronto.

What INOVAIT does

INOVAIT is a non-profit, membership-based national network founded in 2020 and hosted at the Sunnybrook Research Institute in Toronto, dedicated to advancing image-guided therapy (IGT) integrated with artificial intelligence across Canada. The organization is funded by the Government of Canada's Strategic Response Fund (part of the Strategic Innovation Fund) and is not incorporated as a separate commercial entity, operating instead as a program under SRI's governance. Its core offering is a platform of interconnected programs: non-dilutive funding vehicles (Pilot Fund up to $150K CAD per 9-12 month project; Focus Fund up to $2M CAD per 2-3 year project), experiential training (the Medventions fellowship and lecture series), networking events (annual Discovery Forum and IGT Symposium), and a health data licensing toolkit and governance framework designed to help Canadian healthcare institutions safely share data for AI commercialization.

INOVAIT does not generate commercial revenue or sell products; its operating model is that of a government-funded intermediary that channels capital, training, and ecosystem connectivity to Canadian medtech SMEs, academic institutions, hospital research centres, and not-for-profit organizations working on AI-enabled medical imaging, diagnostics, and precision treatments. As of mid-2026, the network had funded more than 100 collaborative R&D projects with cumulative sector infusion exceeding $128M, supporting named companies such as Perimeter Medical Imaging AI, KA Imaging, Hyivy Health, Vope Medical, Daxsonics, Synaptive Medical, Sonic Incytes, 16 Bit, Altis Labs, and Dova Health.

The organization maintains a small staff of approximately 10-12 members led by Co-Executive Directors Kullervo Hynynen (VP Research and Innovation at SRI) and Raphael Ronen (Director, Commercialization and Administration), supported by a board that includes executives from Fusion Pharmaceuticals, McKinsey, and Augmentr Inc. Distribution is primarily through membership enrollment, open funding calls, and in-person events, with strategic partnerships formalized in 2026 with DIGITAL (Canada's Global Innovation Cluster) and Mitacs (fellowship umbrella). The 2026 launch of the 'Navigating the Canadian Image-guided Therapy Sector' market research series extends INOVAIT's role from funder into sector intelligence provider.

INOVAIT firmographics

Firmographics
Name
INOVAIT
Legal name
INOVAIT
Website
https://inovait.ca
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
INOVAIT is a federally funded Canadian network that provides non-dilutive grants, training, and ecosystem connectivity to medtech SMEs, academic institutions, and hospitals working on AI-integrated image-guided therapy, operated from Sunnybrook Research Institute in Toronto.
Ownership category
akta.pro rank

INOVAIT industry classification

Industry
Product category
Medtech Innovation Network
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)

Keywords

  • Image-guided therapy network
  • Medtech commercialization funding
  • AI medical imaging programs
  • Health data licensing tools
  • Medtech entrepreneur training

Where INOVAIT is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

INOVAIT business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Government Funding (Strategic Response Fund): INOVAIT receives funding from the Government of Canada's Strategic Response Fund (part of the Strategic Innovation Fund) to support the Canadian IGT sector, fuel better patient care, and develop image-guided therapy technologies. This non-dilutive funding is used to provide grants to member companies and institutions.
  2. Membership Fees: INOVAIT operates as a membership-based national network. Members receive exclusive access to events, funding opportunities, training programs, and networking with industry leaders in the IGT-AI sector.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractPilot Fund - Up to $150,000 for 9-12 month projects
OtherMulti-year contractFocus Fund - Up to $2 million for 2-3 year projects

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

INOVAIT product offering

Product offering

Core offering

INOVAIT operates as Canada's national image-guided therapy (IGT) and artificial intelligence (AI) network, delivering a connected platform of programs that fund, train, and connect Canadian medtech ventures. Its core services include non-dilutive funding through the Pilot Fund (up to $150,000 CAD) and Focus Fund (up to $2 million CAD), experiential training through the Medventions fellowship program and lecture series, networking through the Discovery Forum and IGT Symposium, and health data licensing frameworks and toolkits. Members include Canadian SMEs, academic institutions, hospital research centres, and not-for-profit organizations working on AI integration in medical imaging, diagnostics, and image-guided therapeutics.

Product overview

INOVAIT is Canada's national image-guided therapy (IGT) and AI network that operates as a platform of interconnected programs rather than a single product. The core offerings include two non-dilutive funding vehicles—the Pilot Fund (up to $150K for 9-12 month projects) and Focus Fund (up to $2M for multi-year projects)—that support collaborative R&D integrating AI into medical imaging technologies. Complementing funding are the Medventions training programs (fellowship and lecture series) that develop medtech talent, networking events (Discovery Forum and IGT Symposium) that connect the ecosystem, and data licensing tools that enable responsible health data sharing for innovation. Together, these programs form a comprehensive commercialization support ecosystem for Canadian medtech companies.

Differentiator

Problem solved

Functional benefit

Brands

  • Medventions: A medtech innovation fellowship program that targets clinical needs and nurtures Canada's rising medtech talent base. Founded at Sunnybrook Research Institute, it immerses fellows in real clinical settings to identify unmet clinical needs and develop innovations in healthcare.
  • Discovery Forum
  • IGT Symposium
  • Lecture Series

Products and services

  • Pilot Fund Non-dilutive funding program providing up to $150,000 CAD per 9–12 month project, reimbursing up to one-third of eligible costs for collaborative R&D projects integrating AI with image-guided therapy technologies. Targets Canadian corporations, academic institutions, hospitals, and not-for-profit organizations.
  • Focus Fund Non-dilutive funding program providing up to $2 million CAD per 2–3 year project for high technical and clinical merit projects with highest commercialization potential, supporting larger-scale IGT-AI development initiatives.
  • Medventions Fellowship Program Elite medtech entrepreneur training program providing clinical immersion, mentorship, and prototyping funding to aspiring healthcare innovators. Operating in Ontario, Nova Scotia, and Newfoundland and Labrador through a formal partnership with Mitacs.
  • Medventions Lecture Series Educational lecture series addressing the role of big data in image-guided therapy and the integration of AI data handling into IGT technologies, designed for students, entrepreneurs, and scientists seeking introductory knowledge of the field.
  • Discovery Forum Annual members-only flagship event featuring cutting-edge image-guided therapy technology showcases, panel discussions, and project progress presentations for academic-industry networking.
  • IGT Symposium Annual two-day scientific conference bringing together clinical and research communities for emerging diagnostic and therapeutic health technologies, including biomedical imaging, AI, machine learning, and image-guided therapeutics.
  • Health Data Licensing Toolkit Free toolkit for Canadian healthcare institutions to safely and responsibly share data for commercial development of AI technologies, including data licensing frameworks and governance guidelines.
  • Principles for Safe, Ethical, and Trustworthy Canadian Health Data Licensing Framework document for healthcare institutions to confidently engage in health data licensing, grounded in transparency, ethical practices, patient representation, governance, and Indigenous data sovereignty.
  • Navigating the Canadian Image-guided Therapy Sector Series Multi-installment market research initiative chronicling experiences of 30 Canadian IGT companies, analyzing funding sources, ecosystem gaps, and recommendations for sector growth.

Companies that use INOVAIT

Customer profile

Named customers12 records

Segments4 records

Ideal customer profiles4 records

INOVAIT technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

INOVAIT partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • MitacscoreStrategic or Co-development Partner · 9 June 2026Medventions Mitacs Umbrella agreement supporting fellowship programs across Canada (Ontario, Nova Scotia, and Newfoundland and Labrador) over two years. The partnership will support 39 internships within the Medventions program, equipping medtech entrepreneurs with hands-on clinical experience. The partnership formalizes a relationship that began in 2021.
  • DIGITALcoreStrategic or Co-development Partner · 31 March 2026MOU signed to formalize collaboration expanding opportunities for IGT founders and accelerating commercialization. Framework includes bi-directional referrals, cross-promotion of programming, exploration of joint co-innovation calls, and expanded participation in ecosystem-building activities. Builds on previous co-investments in Dova Health, 16 Bit, and Altis Labs.
  • Sunnybrook Research InstitutecoreStrategic or Co-development Partner · 1 January 2020INOVAIT was established in 2020 at Sunnybrook Research Institute, which serves as the host organization. SRI is the research arm of Sunnybrook Health Sciences Centre, one of Canada's premier academic health sciences centres fully affiliated with the University of Toronto. SRI is home to the Centre for Research in Image-Guided Therapeutics.
  • Dova HealthminorStrategic or Co-development PartnerHigh-impact Canadian IGT company that has received co-investment support from both INOVAIT and DIGITAL at different stages of their journey.
  • 16 BitminorStrategic or Co-development PartnerHigh-impact Canadian IGT company that has received co-investment support from both INOVAIT and DIGITAL at different stages of their journey.
  • Altis LabsminorStrategic or Co-development PartnerHigh-impact Canadian IGT company that has received co-investment support from both INOVAIT and DIGITAL at different stages of their journey.
  • University of TorontocoreStrategic or Co-development PartnerMajor academic partner through Sunnybrook Research Institute affiliation. INOVAIT works with various university departments including Department of Medical Biophysics, Department of Biophysics, and Department of Chemistry for IGT research and commercialization.
  • University of WaterloocoreStrategic or Co-development PartnerAcademic partner collaborating on multiple funded projects including KA Imaging's AI-based triage tool and Hyivy Health's AI-enabled therapy system.
  • University Health NetworkcoreStrategic or Co-development PartnerMajor hospital research centre partner collaborating on projects including Vope Medical's CLARIS platform and Altis Labs' deep learning system for lung cancer treatment decisions.
  • Nova Scotia Health AuthoritycoreStrategic or Co-development PartnerMajor Atlantic Canada health authority partner, recipient of INOVAIT Aurora Borealis Award, and partner in Medventions Atlantic program and various IGT research projects.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

INOVAIT competitors and assessment

Company assessment

Emerging players

  • BioEnterprise (Cleveland): US medtech/healthtech commercialization hub providing advisory, capital, and program services to medical device start-ups. Operates a similar model of cohort-based commercialization support but is regional to Northeast Ohio rather than national.

Direct peers

  • Mitacs: Canadian national research network that funds internships and R&D collaborations between academia and industry. INOVAIT's Medventions Mitacs Umbrella Agreement partner; both operate as federal-network intermediaries funding applied research and talent development.
  • MEDTEQ+: Canadian medtech industry consortium funding collaborative R&D projects between SMEs, hospitals, and academia. Closely overlaps INOVAIT's mission of accelerating medtech commercialization via co-investment, training, and networking, with a similar funding-network business model.
  • DIGITAL (Canada's Global Innovation Cluster for digital technologies): Canada's Global Innovation Cluster for digital technologies, INOVAIT's newest MOU partner covering bi-directional referrals and co-investments. Operates the same non-dilutive matching-co-investment model on a larger stage across digital tech, making it the most direct analog to INOVAIT's IGT-AI mandate.
  • OBIO (Ontario Bioscience Innovation Organization): Ontario health-bioscience cluster that invests in and supports early-stage life sciences and healthtech companies, with programs for talent, capital, and commercialization. Comparable mission and instrument set to INOVAIT, though broader in therapeutic scope.

Broad incumbents

  • Creative Destruction Lab (CDL): Seed-stage accelerator affiliated with the University of Toronto, hosting health-focused streams (CDL-Healthech). Similar Canadian innovation-ecosystem pedigree, but operating via equity-mentorship cohorts rather than non-dilutive grants.
  • MaRS Discovery District: Canada's largest urban innovation hub hosting healthtech ventures, programming, and capital connections. Operates a similar network-and-ecosystem model in Toronto, but with a much broader sector mandate than INOVAIT's IGT-specific focus.
  • Innovate UK (Health & Life Sciences): UK government-backed innovation agency funding late-stage R&D and commercialization in priority sectors including health and life sciences. Analogous in role as a national-level public innovation funder targeting medtech/healthcare innovation.

Others

  • SOSV (IndieBio): Venture firm and accelerator network with health/biotech programs running cohort-based commercialization support. Comparable in building founder/venture ecosystems in healthtech, though capital-based (equity) rather than grant-based like INOVAIT.

Regional players

  • Healthtech Innovation Hub (HTX): Healthtech-focused accelerator and network focused on commercialization support in adjacent medtech and digital health. Comparable funding-and-network operating model but with different therapeutic emphasis and non-Canadian footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

INOVAIT social profiles

Digital presence

INOVAIT financial estimates

Financial estimate

Revenue estimate

Valuation estimate

INOVAIT leadership team

Management profile

Number of profiles

Profiles15 records

INOVAIT funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

INOVAIT M&A and investment

M&A and investment

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INOVAIT

What does INOVAIT do?

INOVAIT operates as Canada's national image-guided therapy (IGT) and artificial intelligence (AI) network, delivering a connected platform of programs that fund, train, and connect Canadian medtech ventures. Its core services include non-dilutive funding through the Pilot Fund (up to $150,000 CAD) and Focus Fund (up to $2 million CAD), experiential training through the Medventions fellowship program and lecture series, networking through the Discovery Forum and IGT Symposium, and health data licensing frameworks and toolkits. Members include Canadian SMEs, academic institutions, hospital research centres, and not-for-profit organizations working on AI integration in medical imaging, diagnostics, and image-guided therapeutics.

Is INOVAIT a public or private company?

INOVAIT is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was INOVAIT founded?

INOVAIT was founded in 2020. It employs 1 to 10 people.

Where is INOVAIT based?

INOVAIT is headquartered in Toronto, Canada, in the North America region.

How does INOVAIT make money?

Two revenue lines are on record. Government Funding (Strategic Response Fund) is the primary driver. The others are membership Fees.

Who are INOVAIT's main competitors?

BioEnterprise (Cleveland) is listed as an emerging player. Direct peers are Mitacs, MEDTEQ+, DIGITAL (Canada's Global Innovation Cluster for digital technologies) and OBIO (Ontario Bioscience Innovation Organization). Broad incumbents are Creative Destruction Lab (CDL), MaRS Discovery District and Innovate UK (Health & Life Sciences). SOSV (IndieBio) is listed as an others. Healthtech Innovation Hub (HTX) is listed as a regional player.

Does INOVAIT have an API?

No public API is recorded for INOVAIT.

What industry is INOVAIT in?

INOVAIT's product category is Medtech Innovation Network. Its primary akta.pro industry code is HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 5417 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MorningstarillumiSonics and Sunnybrook Launch INOVAIT Focus Fund–Backed Clinical Trial Bringing Label-Free Laser Histology to Mohs Skin Cancer SurgeryillumiSonics and Sunnybrook launched a prospective clinical trial at Sunnybrook Health Sciences Centre to evaluate its Multi-Laser Imaging (MLI) platform for skin cancer margin assessment during Mohs surgery. The single-centre study will enroll up to 200 patients between July 2026 and December 2028, with the primary endpoint being diagnostic agreement measured by Cohen's kappa. The trial is supported by the INOVAIT Focus Fund.Business Wire BlogillumiSonics and Sunnybrook Launch INOVAIT Focus Fund–Backed Clinical Trial Bringing Label-Free Laser Histology to Mohs Skin Cancer SurgeryillumiSonics Inc. has launched a prospective clinical validation study at Sunnybrook Health Sciences Centre in Toronto to evaluate its Multi-Laser Imaging (MLI) platform for skin cancer margin assessment during Mohs micrographic surgery, enrolling up to 200 patients between July 2026 and December 2028. The study, supported by the INOVAIT Focus Fund with contributions from the Government of Canada's Strategic Response Fund, aims to test MLI virtual histology against standard-of-care frozen-section histology using six masked board-certified pathologists. The technology, based on Photon Absorption Remote Sensing (PARS), previously demonstrated greater than 95% agreement with conventional histology in retrospective work and could reduce the current 60-minute cycle time per Mohs surgery stage.DAICKA Imaging Project Selected for INOVAIT Pilot FundKA Imaging has been selected for the INOVAIT Pilot Fund to develop an AI-based triage tool for pulmonary health using data from its Reveal 35C detector with SpectralDR technology, in collaboration with Dr. Elliot Creager at the University of Waterloo. The tool is intended to assist non-radiologist clinicians in rapidly identifying cardiothoracic abnormalities before and after image-guided interventions, with a demonstration expected in 2027. Following successful development, validation, and regulatory clearances, the resulting software will be integrated with KA Imaging's mobile spectral X-ray systems to automatically analyze bedside spectral X-rays and prioritize cases for clinician review.MarketScreenerPerimeter Selected for INOVAIT Pilot Fund to Advance AI for Breast Cancer SurgeryPerimeter Medical Imaging AI has been selected to receive nearly $148,000 from the INOVAIT Pilot Fund to advance next-generation AI capabilities for its FDA-approved Claire™ intraoperative imaging platform used during breast cancer surgery. The project, one of 10 selected in the latest funding round, will focus on developing more robust AI tools including reducing manual expert labeling burden, improving AI performance across different tissue types, and designing a two-tier AI architecture for surgical workflow optimization. An additional $100,000 Mitacs Business Strategy Internship award will support graduate student participation through collaboration with the University of Toronto.Financial PostINOVAIT and Government of Canada Fund New R&D Projects in AI-Powered Image-Guided TherapyINOVAIT announced 10 recipients of its Pilot Fund at the Medventions Toronto Innovation Day, committing $1.35 million to support collaborative R&D projects in AI-powered image-guided therapy across Canada. The combined value of the selected projects is nearly $4.16 million, contributed by all project participants along with INOVAIT, supporting collaborations between small- and medium-sized enterprises, hospital research centres, and academic institutions. The funding is made possible through the Government of Canada's Strategic Response Fund, with the goal of advancing medtech innovation and commercialization in Canada's healthcare sector.GeneOnline NewsPerimeter Medical Imaging AI Receives INOVAIT Funding for Breast Cancer Surgical Tool DevelopmentPerimeter Medical Imaging AI has secured funding from the INOVAIT Pilot Fund to develop AI-powered imaging technology for breast cancer surgery. The technology aims to provide real-time tissue assessment feedback to surgeons during lumpectomies, potentially reducing the need for follow-up surgeries. The project is supported by Canada's Strategic Innovation Fund and will accelerate the clinical development and testing of Perimeter's AI-enhanced imaging platform.PR NewswirePerimeter Selected for INOVAIT Pilot Fund to Advance AI for Breast Cancer SurgeryPerimeter Medical Imaging AI has been selected to receive up to nearly $148,000 from the INOVAIT Pilot Fund, alongside an additional $100,000 Mitacs Business Strategy Internship award, to advance next-generation AI capabilities for its Claire™ platform. The project, conducted in partnership with the University of Toronto, will focus on building more robust AI infrastructure including tools to reduce manual labeling burden, improving AI performance across tissue types, designing a two-tier screening architecture, and optimizing hardware performance for operating room environments. Claire received FDA approval earlier this year as the first AI-enabled imaging device for intraoperative use during breast cancer surgery, addressing the clinical challenge where approximately one in four women undergoing breast-conserving surgery currently requires a follow-on procedure.Stock TitanPerimeter lands INOVAIT funding for Claire AIPerimeter Medical Imaging AI has been selected to receive up to $148,000 from the INOVAIT Pilot Fund, a Canadian government-backed initiative, to advance next-generation AI capabilities for its Claire™ platform, which received U.S. FDA approval earlier this year as the first AI-enabled imaging device for use during breast cancer surgery. The project will focus on building more robust AI infrastructure, including tools to reduce manual labeling burden, improve AI performance across different tissue types, and design a two-tier architecture for surgical workflow integration. The work is being conducted in partnership with the University of Toronto and is expected to proceed through standard FDA review processes for future deployments.NewswirePerimeter Selected for INOVAIT Pilot Fund to Advance AI for Breast Cancer SurgeryPerimeter Medical Imaging AI was selected for an INOVAIT Pilot Fund contribution to advance AI for its FDA-approved Claire breast cancer surgery imaging device. The company expects up to $148,000 in funding, with a $100,000 internship award, to build more robust AI infrastructure. The project targets four areas including reducing manual labeling and optimizing for operating-room hardware.